Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03980275 · ClinicalTrials.gov registry record

Selective Laryngeal Reinnervation for Bilateral Vocal Fold Paralysis

A clinical trial of Bilateral Vocal Cord Paralysis, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
15
Enrollment target
1
Study location

NCT03980275 is a study of Bilateral Vocal Cord Paralysis that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03980275, a study of Bilateral Vocal Cord Paralysis, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
15 participants
Enrollment target
1
Study location

Study Summary

This is a prospective observational study examining the treatment outcomes of selective laryngeal reinnervation procedures for patients with bilateral vocal fold paralysis.

Study Locations (1)

New York

  • Sean Parker Institute for the Voice - New York

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2019-12-10
Est. Completion 2030-12-31

What the Registry Record Tells You About NCT03980275

The ClinicalTrials.gov registry entry for NCT03980275 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Bilateral Vocal Cord Paralysis appearing as the primary indexed condition, and to 0 interventions.

NCT03980275 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03980275 about?

NCT03980275 is a clinical study titled "Selective Laryngeal Reinnervation for Bilateral Vocal Fold Paralysis". This is a prospective observational study examining the treatment outcomes of selective laryngeal reinnervation procedures for patients with bilateral vocal fold paralysis.

What is the current status of trial NCT03980275?

This trial is currently recruiting. The enrollment target is 15 participants. The study started on 2019-12-10. Estimated completion is 2030-12-31.

What conditions does trial NCT03980275 study?

This clinical trial studies the following conditions: Bilateral Vocal Cord Paralysis.

Who is sponsoring clinical trial NCT03980275?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03980275 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.